May 26, 2011

NASDAQ OMX (NASDAQ:NDAQ) announces that Moberg Derma AB (ticker symbol: MOB), a small cap company within the Health Care sector, today starts trading of its shares on the main market of NASDAQ OMX Stockholm. Moberg Derma is the fourth company to list at NASDAQ OMX European markets in 2011.

Moberg Derma is a Swedish pharmaceutical company, which in five years has created an interesting product and project portfolio with annual sales potential exceeding SEK 3 billion at the distribution level. The portfolio covers approved and launched products to projects in the preclinical phase. Moberg Derma’s business idea is to develop patented topical pharmaceuticals for treatment of commonly prevailing diseases by using innovative drug delivery. Moberg Dermas products are based on proven compounds, which reduce time to market, development costs and risk. Read more about Moberg Derma AB »


Follow Moberg Derma AB`s share information here »


View the film from the listing ceremony on May 26, 2011 here »



Peter Wolpert, CEO and founder of Moberg Derma is tolling the bell to celebrate the first day of trading.
Peter Wolpert receives a listing crystal from NASDAQ OMX, welcoming Moberg Derma to NASDAQ OMX family.

Peter Wolbert is awaiting in the first trade made in Moberg Derma AB´s share.
  Representatives from Moberg Derma AB gathered together to celebrate the first day of trading together with their Advisor.